المؤلفون: Casselini, Carolina M, Parson, Henri K, Frizzi, Katie E, Marquez, Alex, Smith, Darrell R, Guernsey, Lucie, Nemmani, Rakesh, Tayarani, Alireza, Jolivalt, Corinne G, Weaver, Jessica, Fernyhough, Paul, Vinik, Aaron I, Calcutt, Nigel A

المصدر: Acta Neuropathologica. 147(1)

مصطلحات موضوعية: Pharmacology and Pharmaceutical Sciences, Biomedical and Clinical Sciences, Neurosciences, Clinical Sciences, Neurodegenerative, Peripheral Neuropathy, Clinical Research, Chronic Pain, Diabetes, Clinical Trials and Supportive Activities, Pain Research, Development of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 5.2 Cellular and gene therapies, Evaluation of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Metabolic and endocrine, Neurological, Diabetic neuropathy, Epidermal nerve fibres, Muscarinic antagonist, Neuropathic pain, Oxybutynin, Randomized clinical trial, Animals, Humans, Mice, Rats, Diabetic Neuropathies, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Mandelic Acids, Receptors, Muscarinic, Muscarinic Antagonists, Quality of Life, Adult, Diabetes Mellitus, Type 1, Neurology & Neurosurgery

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/8jf8v1cqTest

المؤلفون: Jolivalt, Corinne G, Han, May Madi, Nguyen, Annee, Desmond, Fiona, Alves Jesus, Carlos Henrique, Vasconselos, Daniela C, Pedneault, Andrea, Sandlin, Natalie, Dunne-Cerami, Sage, Frizzi, Katie E, Calcutt, Nigel A

المصدر: Journal of Clinical Medicine. 11(9)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Neurosciences, Ophthalmology and Optometry, Neurodegenerative, Peripheral Neuropathy, Physical Injury - Accidents and Adverse Effects, Prevention, Diabetes, Chronic Pain, Pain Research, Eye Disease and Disorders of Vision, 5.2 Cellular and gene therapies, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Eye, Neurological, diabetic neuropathy, corneal confocal microscopy, CNTF, GLP-1, exendin-4, muscarinic antagonist, cyclopentolate, glycopyrrolate, gallamine, Clinical Sciences, Biomedical and clinical sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/60v5q7r7Test

المؤلفون: Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS

المصدر: International Journal of COPD, Vol Volume 18, Pp 643-659 (2023)

مصطلحات موضوعية: adherence, comparative effectiveness, chronic obstructive pulmonary disease (copd) treatment, inhaled corticosteroid/long-acting β2-agonist (ics/laba) dual therapy, long-acting muscarinic antagonist (lama)/laba dual therapy, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/comparative-effectiveness-of-umeclidiniumvilanterol-versus-inhaled-cor-peer-reviewed-fulltext-article-COPDTest; https://doaj.org/toc/1178-2005Test

الوصول الحر: https://doaj.org/article/674380042cfa490fa62e917371ce6c70Test

المؤلفون: Kerwin, Edward M., Jones, Paul W., Bjermer, Leif H., Maltais, François, Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Tombs, Lee, Vogelmeier, Claus F.

المصدر: Chronic Respiratory Disease EpiHealth: Epidemiology for Health. 20

مصطلحات موضوعية: initial maintenance therapy, long-acting bronchodilators, long-acting muscarinic antagonist/long-acting β-agonist dual therapy, primary care, Symptomatic chronic obstructive pulmonary disease, Medicin och hälsovetenskap, Klinisk medicin, Lungmedicin och allergi, Medical and Health Sciences, Clinical Medicine, Respiratory Medicine and Allergy

الوصول الحر: https://lup.lub.lu.se/record/00656abb-9351-4ddd-817e-c84d441dbc2fTest
http://dx.doi.org/10.1177/14799731231202257Test

المؤلفون: Toetik Aryani, Riska K. Rahmawati, Ni P. Cintyadewi, Arina D. Puspitasari, Alfian N. Rasyid, Samirah Samirah

المصدر: Journal of Public Health in Africa, Vol 14, Iss 1 (2023)

مصطلحات موضوعية: asthma, β2 agonists, muscarinic antagonist, inhaled corti-costeroids, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

العلاقة: https://publichealthinafrica.org/index.php/jphia/article/view/164Test; https://doaj.org/toc/2038-9922Test; https://doaj.org/toc/2038-9930Test

الوصول الحر: https://doaj.org/article/2a6dbb4858cd4a1b8d8d87ac51103a71Test

المؤلفون: Mannino D, Siddall J, Small M, Haq A, Stiegler M, Bogart M

المصدر: International Journal of COPD, Vol Volume 17, Pp 749-761 (2022)

مصطلحات موضوعية: copd, survey, inhaled corticosteroids, long-acting β2-agonist, long-acting muscarinic antagonist, maintenance therapy, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/treatment-patterns-for-chronic-obstructive-pulmonary-disease-copd-in-t-peer-reviewed-fulltext-article-COPDTest; https://doaj.org/toc/1178-2005Test

الوصول الحر: https://doaj.org/article/b7a12cc79006420c873efd08ffe9b6dcTest

المؤلفون: Miravitlles M, Verhamme K, Calverley PMA, Dreher M, Bayer V, Gardev A, de la Hoz A, Wedzicha J, Price D

المصدر: International Journal of COPD, Vol Volume 17, Pp 545-558 (2022)

مصطلحات موضوعية: copd, exacerbation history, inhaled corticosteroid, long-acting β2-agonist, long-acting muscarinic antagonist, mortality, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/a-pooled-analysis-of-mortality-in-patients-with-copd-receiving-dual-br-peer-reviewed-fulltext-article-COPDTest; https://doaj.org/toc/1178-2005Test

الوصول الحر: https://doaj.org/article/fef1045653fb44cf88345b8a595a0827Test

المؤلفون: Van Zyl-Smit, Richard N., Kerstjens, Huib AM, Maspero, Jorge F., Kostikas, Konstantinos, Hosoe, Motoi, Tanase, Ana Maria, D'Andrea, Peter, Mezzi, Karen, Brittain, Dominic, Lawrence, David, Chapman, Kenneth R.

المصدر: Van Zyl-Smit , R N , Kerstjens , H AM , Maspero , J F , Kostikas , K , Hosoe , M , Tanase , A M , D'Andrea , P , Mezzi , K , Brittain , D , Lawrence , D & Chapman , K R 2023 , ' Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation : Post hoc analysis from the IRIDIUM study ' , Respiratory Medicine , vol. 211 , 107172 . https://doi.org/10.1016/j.rmed.2023.107172Test

مصطلحات موضوعية: Asthma, Efficacy, Exacerbations, Long-acting muscarinic antagonist, Lung function, Persistent airflow limitation

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/f4c1fd23-4d86-43bd-924d-b762b36d021aTest

الإتاحة: https://doi.org/10.1016/j.rmed.2023.107172Test
https://hdl.handle.net/11370/f4c1fd23-4d86-43bd-924d-b762b36d021aTest
https://research.rug.nl/en/publications/f4c1fd23-4d86-43bd-924d-b762b36d021aTest
https://pure.rug.nl/ws/files/697741280/Efficacy_of_once-daily_single-inhaler_fixed-dose_combination_of_mometasone_indacaterol_glycopyrronium_in_patients_with_asthma_with_or_without_persistent_airflow_limitation_Post_hoc_analysis_from_the_IRIDIUM_study.pdfTest

المؤلفون: Joseph Antony Jude, Ian Dainty, Nikhil Karmacharya, William Jester, Reynold Panettieri

المصدر: Cells; Volume 12; Issue 2; Pages: 240

مصطلحات موضوعية: human airways, asthma, navafenterol, muscarinic antagonist and β 2 AR agonist, human precision-cut lung slice

وصف الملف: application/pdf

العلاقة: Cell Motility and Adhesion; https://dx.doi.org/10.3390/cells12020240Test

الإتاحة: https://doi.org/10.3390/cells12020240Test

المؤلفون: L. A. Shpagina, O. S. Kotova, I. S. Shpagin, G. V. Kuznetsova, S. A. Karmanovskaya, L. A. Panacheva, E. V. Anikina, Л. А. Шпагина, О. С. Котова, И. С. Шпагин, Г. В. Кузнецова, С. А. Кармановская, Л. А. Паначева, Е. В. Аникина

المساهمون: Federal budget funds for the implementation of state task No.056-00034-21-00 were used, Исследование осуществлялось за счет средств федерального бюджета на исполнение государственного задания № 05600034-21-00

المصدر: PULMONOLOGIYA; Том 33, № 6 (2023); 739-749 ; Пульмонология; Том 33, № 6 (2023); 739-749 ; 2541-9617 ; 0869-0189

مصطلحات موضوعية: длительно действующие антихолинергические препараты, exacerbation, respiratory viral infection, inhaled corticosteroid, long-acting β2-agonist, longacting muscarinic antagonist, обострение, респираторная вирусная инфекция, ингаляционные глюко-кортикостероиды, длительно действующие β2-агонисты

وصف الملف: application/pdf

العلاقة: https://journal.pulmonology.ru/pulm/article/view/4372/3578Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4372/2183Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4372/2184Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4372/2185Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4372/2186Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4372/2187Test; GBD 2019 Chronic Respiratory Diseases Collaborators. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the global burden of disease study 2019. EClinicalMedicine. 2023; 59: 101936. DOI:10.1016/j.eclinm.2023.101936.; Федеральная служба государственной статистики (Росстат). Российский статистический ежегодник: статистический сборник. М; 2022. Доступно на: https://rosstat.gov.ru/storage/mediabank/Ejegodnik_2022.pdfTest; Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 963–974. DOI:10.2147/COPD.S67283.; Быстрицкая Е.В., Биличенко Т.Н. Заболеваемость, инвалидность и смертность от болезней органов дыхания в Российской Федерации (2015–2019). Пульмонология. 2021; 31 (5): 551–561. DOI:10.18093/0869-0189-2021-31-5-551-561.; Brightling C., Greening N. Airway inflammation in COPD: progress to precision medicine. Eur. Respir. J. 2019; 54 (2): 1900651. DOI:10.1183/13993003.00651-2019.; Шпагина Л.А., Котова О.С., Сараскина Л.Е., Ермакова М.А. Особенности клеточно-молекулярных механизмов профессиональной хронической обструктивной болезни легких. Сибирское медицинское обозрение. 2018; 110 (2): 37–45. DOI:10.20333/2500136-2018-2-37-45.; Wu J.J., Xu H.R., Zhang Y.X. et al. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review. BMC Pulm. Med. 2020; 20 (1): 103. DOI:10.1186/s12890-020-1126-x.; Зыков К.А., Овчаренко С.И., Авдеев С.Н. и др. Фенотипические характеристики пациентов с хронической обструктивной болезнью легких, имеющих стаж курения, в Российской Федерации: данные исследования POPE-study. Пульмонология. 2020; 30 (1): 42–52. DOI:10.18093/0869-0189-2020-30-1-42-52.; Müllerová H., Marshall J., de Nigris E. et al. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis. Adv. Respir. Dis. 2022; 16: 17534666221113647. DOI:10.1177/17534666221113647.; Ghebre M.A., Pang P.H., Diver S. et al. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles. J. Allergy Clin. Immunol. 2018; 141 (6): 2027–2036.e12. DOI:10.1016/j.jaci.2018.04.013.; Hurst J.R., Han M.K., Singh B. et al. Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respir. Res. 2022; 23 (1): 213. DOI:10.1186/s12931-022-02123-5.; Visseaux B., Burdet C., Voiriot G. et al. Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016. PLoS One. 2017; 12 (7): e0180888. DOI:10.1371/journal.pone.0180888.; Jafarinejad H., Moghoofei M., Mostafaei S. et al. Worldwide prevalence of viral infection in AECOPD patients: a meta-analysis. Microb. Pathog. 2017; 113: 190–196. DOI:10.1016/j.micpath.2017.10.021.; Liao K.M., Chen Y.J., Shen C.W. et al. The influence of influenza virus infections in patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2022; 17: 2253–2261. DOI:10.2147/COPD.S378034.; Mahmud S.M.H., Al-Mustanjid M., Akter F. et al. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients. Brief. Bioinform. 2021; 22 (5): bbab115. DOI:10.1093/bib/bbab115.; Guo-Parke H., Linden D., Weldon S. et al. Mechanisms of virus-induced airway immunity dysfunction in the pathogenesis of COPD disease, progression, and exacerbation. Front. Immunol. 2020; 11: 1205. DOI:10.3389/fimmu.2020.01205.; D'Anna S.E., Maniscalco M., Cappello F. et al. Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease. Ann. Med. 2021; 53 (1): 135–150. DOI:10.1080/07853890.2020.1831050.; Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Хроническая обструктивная болезнь легких: федеральные клинические рекомендации по диагностике и лечению. Пульмонология. 2022; 32 (3): 356–392. DOI:10.18093/0869-0189-2022-32-3-356-392.; Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of COPD: 2023 COLD Report. Available at: https://goldcopd.org/2023-gold-report-2Test/ [Assecced: August 04, 2023].; Авдеев С.Н., Айсанов З.Р., Архипов В.В. и др. Назначение / отмена ингаляционных глюкокортикостероидов у больных хронической обструктивной болезнью легких как терапевтический континуум в реальной клинической практике. Пульмонология. 2023; 33 (1): 109–118. DOI:10.18093/0869-0189-2023-33-1-109-118.; Alcázar-Navarrete B, Jamart L, Sánchez-Covisa J. et al. Clinical characteristics, treatment persistence, and outcomes among patients with COPD treated with single- or multiple-inhaler triple therapy: a retrospective analysis in Spain. Chest. 2022; 162 (5): 1017–1029. DOI:10.1016/j.chest.2022.06.033.; Jones P.W., Harding G., Berry P. et al. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 2009; 34 (3): 648–654. DOI:10.1183/09031936.00102509.; Чучалин А.Г., Айсанов З.Р., Чикина С.Ю. и др. Федеральные клинические рекомендации Российского респираторного общества по использованию метода спирометрии. Пульмонология. 2014; (6): 11–24. DOI:10.18093/0869-0189-2014-0-6-11-24.; Graham B.L., Brusasco V., Burgos F. et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur. Respir. J. 2017; 49 (1): 1600016. DOI:10.1183/13993003.00016-2016.; ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166 (1): 111–117. DOI:10.1164/ajrccm.166.1.at1102.; Puhan M.A., Chandra D., Mosenifar Z. et al. The minimal important difference of exercise tests in severe COPD. Eur. Respir. J. 2011; 37 (4): 784–790. DOI:10.1183/09031936.00063810.; Шпагина Л.А., Котова О.С., Шпагин И.С. и др. Клинико-функциональные особенности хронической обструктивной болезни легких после вирус-ассоциированных обострений. Терапевтический архив. 2023; 95 (3): 217–222. DOI:10.26442/00403660.2023.03.202086.; Singh D., Papi A., Corradi M. et al. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. Lancet. 2016; 388 (10048): 963–973. DOI:10.1016/s0140-6736(16)31354-x.; Lipson D.A., Barnhart F., Brealey N. et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N. Engl. J. Med. 2018; 378 (18): 1671–1680. DOI:10.1056/NEJMoa1713901.; Ferguson G.T., Rabe K.F., Martinez F.J. et al. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. Lancet Respir. Med. 2018; 6 (10): 747–758. DOI:10.1016/S2213-2600(18)30327-8.; Halpin D.M.G., Kendall R., Shukla S. et al. Cost-effectiveness of single- versus multiple-inhaler triple therapy in a UK COPD population: the INTREPID trial. Int. J. Chron. Obstruct. Pulmon. Dis. 2022; 17: 2745–2755. DOI:10.2147/COPD.S370577.; Ferguson G.T., Brown N., Compton C. et al. Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials. Respir. Res. 2020; 21 (1): 131. DOI:10.1186/s12931-020-01360-w.; David B., Bafadhel M., Koenderman L., De Soyza A. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. Thorax. 2021; 76 (2): 188–195. DOI:10.1136/thoraxjnl-2020-215167.; Насонов Е.Л., ред. Российские клинические рекомендации: Ревматология. М.: ГЭОТАР-Медиа; 2020.; De Sadeleer L.J., Hermans F., De Dycker E. et al. Effects of corticosteroid treatment and antigen avoidance in a large hypersensitivity pneumonitis cohort: a single-centre cohort study. J. Clin. Med. 2018; 8 (1): 14. DOI:10.3390/jcm8010014.; RECOVERY Collaborative Group; Horby P., Lim W.S. et al. Dexamethasone in hospitalized patients with COVID-19. N. Engl. J. Med. 2021; 384 (8): 693–704. DOI:10.1056/NEJMoa2021436.; Ponce-Gallegos M.A., Ramírez-Venegas A., Falfán-Valencia R. Th17 profile in COPD exacerbations. Int. J. Chron. Obstruct. Pulmon. Dis. 2017; 12: 1857–1865. DOI:10.2147/COPD.S136592.; Su Y., Gu H., Weng D. et al. Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease. Medicine (Baltimore). 2017; 96 (18): e6617. DOI:10.1097/MD.0000000000006617.; https://journal.pulmonology.ru/pulm/article/view/4372Test

الإتاحة: https://doi.org/10.18093/0869-0189-2023-33-6-739-749Test
https://doi.org/10.1016/j.eclinm.2023.101936Test
https://doi.org/10.2147/COPD.S67283Test
https://doi.org/10.18093/0869-0189-2021-31-5-551-561Test
https://doi.org/10.1183/13993003.00651-2019Test
https://doi.org/10.20333/2500136-2018-2-37-45Test
https://doi.org/10.1186/s12890-020-1126-xTest
https://doi.org/10.18093/0869-0189-2020-30-1-42-52Test
https://doi.org/10.1177/17534666221113647Test
https://doi.org/10.1016/j.jaci.2018.04.013Test